メリーランド州における小細胞肺がんの臨床試験
メリーランド州内の拠点で、小細胞肺がんに関する19件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/02更新 · NCT02146170Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT07509034DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- University of Maryland School of Medicine, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07472517Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- United Theranostics, Glen Burnie
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07278479A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/09/22更新 · NCT06066138A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders, Bethesda
- Maryland Oncology Hematology, Silver Spring
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- University of Maryland, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07057791A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜120歳 · 全性別 · 2026/08/13更新 · NCT06228066A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/06更新 · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- University of Maryland School of Medicine, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/23更新 · NCT05882058A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Johns Hopkins University, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/15更新 · NCT0525755118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜120歳 · 全性別 · 2026/05/19更新 · NCT06503146Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- University of Maryland/Greenebaum Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/30更新 · NCT06769126Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/17更新 · NCT05450965ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。